Antiviral therapy.
Rachlis
A R
AR
Department of Medicine, Sunnybrooke Medical Centre, University of Toronto, School of Medicine, Ontario, Canada.
D000212:Acyclovir / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics; D000284:Administration, Oral; D000998:Antiviral Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D017245:Foscarnet; D006558:Herpes Genitalis / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D010212:Papilloma / Q000628:therapy; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012008:Recurrence
D000998:Antiviral Agents; D017245:Foscarnet; D007372:Interferons; D010746:Phosphonoacetic Acid; D000212:Acyclovir